The market is a bloated pig and IRWD is a prime example. Linzess will do no better than Amitiza, which was that great. Plus the 19 million they stated in sales was mainly from stocking pharmacies. I want actual script numbers, if anyone has them? Also, what percent royalties does IRWD get from Forest, I tried looking that up but couldn't find anything. This stock, in my opinion, is way overvalued with their current one drug and will take a big hit when the market corrects.
I am not a basher but rather someone who feels the biotech sector is overbought and IRWD is a prime example. I welcome criticism and would appreciate opposing views. Thanks in advance!